logo
  

Regeneron Pharmaceuticals Inc. (REGN) Rose Past Resistance At The Highs

Regeneron Pharmaceuticals Inc. (REGN) rose steadily until mid-morning Tuesday, but settled into a range for the remainder of the session. The stock closed higher by 13.57 at $413.22.

Regeneron Pharmaceuticals climbed past the upper end of nearly a 1-month trading range Tuesday and set a new high for the year.

For comments and feedback contact: editorial@rttnews.com

Business News

Invest in the Best Pharma Stocks by Subscribing to RTT Biotech Investor.

All eyes were on the U.S. Federal Reserve this week as the bank announced its latest policy decision. Find out the signals given out by Chair Jerome Powell regarding the future path of interest rates. Some key data on the U.S. private sector economy were also released. Other main news included the flash estimates of first quarter GDP from Eurozone. Elsewhere, the Paris-based think tank OECD released its latest round of macroeconomic projections for the global economy.

View More Videos
Follow RTT